We investigated the contribution of non-coding variation to hereditary breast cancer by analyzing intronic variants and 5' upstream regions of BRCA1, BRCA2 and PALB2 in the BEACCON case-control study of over 11,000 participants. This evidence concerns the gene BRCA2 and breast carcinoma.